Cargando…

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging

SIMPLE SUMMARY: The high mortality rate of colorectal cancer (CRC) is associated with metastasis to the liver, which is related to an increased expression of the C-X-C chemokine receptor 4 (CXCR4). We hereby report the first preclinical evaluation of [(68)Ga]Ga-Pentixafor, a radiotracer specifically...

Descripción completa

Detalles Bibliográficos
Autores principales: Benčurová, Katarína, Friske, Joachim, Anderla, Maximilian, Mayrhofer, Manuela, Wanek, Thomas, Nics, Lukas, Egger, Gerda, Helbich, Thomas H., Hacker, Marcus, Haug, Alexander, Mitterhauser, Markus, Balber, Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688097/
https://www.ncbi.nlm.nih.gov/pubmed/36428644
http://dx.doi.org/10.3390/cancers14225549
_version_ 1784836180587577344
author Benčurová, Katarína
Friske, Joachim
Anderla, Maximilian
Mayrhofer, Manuela
Wanek, Thomas
Nics, Lukas
Egger, Gerda
Helbich, Thomas H.
Hacker, Marcus
Haug, Alexander
Mitterhauser, Markus
Balber, Theresa
author_facet Benčurová, Katarína
Friske, Joachim
Anderla, Maximilian
Mayrhofer, Manuela
Wanek, Thomas
Nics, Lukas
Egger, Gerda
Helbich, Thomas H.
Hacker, Marcus
Haug, Alexander
Mitterhauser, Markus
Balber, Theresa
author_sort Benčurová, Katarína
collection PubMed
description SIMPLE SUMMARY: The high mortality rate of colorectal cancer (CRC) is associated with metastasis to the liver, which is related to an increased expression of the C-X-C chemokine receptor 4 (CXCR4). We hereby report the first preclinical evaluation of [(68)Ga]Ga-Pentixafor, a radiotracer specifically targeting human CXCR4, for CRC imaging. We established the chorioallantoic membrane (CAM)-xenograft model for two different human colon cancer cell lines (HT29 and HCT116) in our facility and conducted a thorough histological characterisation of the obtained xenograft tissues. The subsequently performed simultaneous positron emission tomography and magnetic resonance (µPET/MR) scans demonstrated [(68)Ga]Ga-Pentixafor uptake in CAM-xenografts and provided novel insights into the radiotracer distribution in the chick embryonal organism. ABSTRACT: Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Increased expression of CXCR4 has been associated with liver metastasis, disease progression, and shortened survival. Using in vitro cell binding studies and the in ovo model, we aimed to investigate the potential of [(68)Ga]Ga-Pentixafor, a radiotracer specifically targeting human CXCR4, for CRC imaging. Specific membrane binding and internalisation of [(68)Ga]Ga-Pentixafor was shown for HT29 cells, but not for HCT116 cells. Accordingly, [(68)Ga]Ga-Pentixafor accumulated specifically in CAM-xenografts derived from HT29 cells, but not in HCT116 xenografts, as determined by µPET/MRI. The CAM-grown xenografts were histologically characterised, demonstrating vascularisation of the graft, preserved expression of human CXCR4, and viability of the tumour cells within the grafts. In vivo viability was further confirmed by µPET/MRI measurements using 2-[(18)F]FDG as a surrogate for glucose metabolism. [(68)Ga]Ga-Pentixafor µPET/MRI scans showed distinct radiotracer accumulation in the chick embryonal heart, liver, and kidneys, whereas 2-[(18)F]FDG uptake was predominantly found in the kidneys and joints of the chick embryos. Our findings suggest that [(68)Ga]Ga-Pentixafor is an interesting novel radiotracer for CRC imaging that is worth further investigation. Moreover, this study further supports the suitability of the CAM-xenograft model for the initial preclinical evaluation of targeted radiopharmaceuticals.
format Online
Article
Text
id pubmed-9688097
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96880972022-11-25 CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging Benčurová, Katarína Friske, Joachim Anderla, Maximilian Mayrhofer, Manuela Wanek, Thomas Nics, Lukas Egger, Gerda Helbich, Thomas H. Hacker, Marcus Haug, Alexander Mitterhauser, Markus Balber, Theresa Cancers (Basel) Article SIMPLE SUMMARY: The high mortality rate of colorectal cancer (CRC) is associated with metastasis to the liver, which is related to an increased expression of the C-X-C chemokine receptor 4 (CXCR4). We hereby report the first preclinical evaluation of [(68)Ga]Ga-Pentixafor, a radiotracer specifically targeting human CXCR4, for CRC imaging. We established the chorioallantoic membrane (CAM)-xenograft model for two different human colon cancer cell lines (HT29 and HCT116) in our facility and conducted a thorough histological characterisation of the obtained xenograft tissues. The subsequently performed simultaneous positron emission tomography and magnetic resonance (µPET/MR) scans demonstrated [(68)Ga]Ga-Pentixafor uptake in CAM-xenografts and provided novel insights into the radiotracer distribution in the chick embryonal organism. ABSTRACT: Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Increased expression of CXCR4 has been associated with liver metastasis, disease progression, and shortened survival. Using in vitro cell binding studies and the in ovo model, we aimed to investigate the potential of [(68)Ga]Ga-Pentixafor, a radiotracer specifically targeting human CXCR4, for CRC imaging. Specific membrane binding and internalisation of [(68)Ga]Ga-Pentixafor was shown for HT29 cells, but not for HCT116 cells. Accordingly, [(68)Ga]Ga-Pentixafor accumulated specifically in CAM-xenografts derived from HT29 cells, but not in HCT116 xenografts, as determined by µPET/MRI. The CAM-grown xenografts were histologically characterised, demonstrating vascularisation of the graft, preserved expression of human CXCR4, and viability of the tumour cells within the grafts. In vivo viability was further confirmed by µPET/MRI measurements using 2-[(18)F]FDG as a surrogate for glucose metabolism. [(68)Ga]Ga-Pentixafor µPET/MRI scans showed distinct radiotracer accumulation in the chick embryonal heart, liver, and kidneys, whereas 2-[(18)F]FDG uptake was predominantly found in the kidneys and joints of the chick embryos. Our findings suggest that [(68)Ga]Ga-Pentixafor is an interesting novel radiotracer for CRC imaging that is worth further investigation. Moreover, this study further supports the suitability of the CAM-xenograft model for the initial preclinical evaluation of targeted radiopharmaceuticals. MDPI 2022-11-11 /pmc/articles/PMC9688097/ /pubmed/36428644 http://dx.doi.org/10.3390/cancers14225549 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Benčurová, Katarína
Friske, Joachim
Anderla, Maximilian
Mayrhofer, Manuela
Wanek, Thomas
Nics, Lukas
Egger, Gerda
Helbich, Thomas H.
Hacker, Marcus
Haug, Alexander
Mitterhauser, Markus
Balber, Theresa
CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
title CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
title_full CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
title_fullStr CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
title_full_unstemmed CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
title_short CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
title_sort cam-xenograft model provides preclinical evidence for the applicability of [(68)ga]ga-pentixafor in crc imaging
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688097/
https://www.ncbi.nlm.nih.gov/pubmed/36428644
http://dx.doi.org/10.3390/cancers14225549
work_keys_str_mv AT bencurovakatarina camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT friskejoachim camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT anderlamaximilian camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT mayrhofermanuela camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT wanekthomas camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT nicslukas camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT eggergerda camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT helbichthomash camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT hackermarcus camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT haugalexander camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT mitterhausermarkus camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging
AT balbertheresa camxenograftmodelprovidespreclinicalevidencefortheapplicabilityof68gagapentixaforincrcimaging